Product Specification
| Alternative Name: | ET-1 |
| |
| Formula: | C109H159N25O32S5 |
| |
| MW: | 2492.0 |
| |
| Quantity: | *Sold as net peptide weight. |
| |
| Purity: | ≥98% (HPLC) |
| |
| Sequence: | H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys1-Cys15and Cys3-Cys11) |
| |
| Formulation: | Lyophilized. |
| |
| CAS: | 117399-94-7 |
| |
| MI: | 14: 3576 |
| |
| RTECS: | KE9446500 |
| |
| Solubility: | 1mg/ml soluble in DMSO or 5% acetic acid. |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Solution is stable for 1-2 weeks when stored at -20°C. Prepare solution just before use. |
| |
Product Literature References
G.J. Price & L. Malone; Nucl. Acids Res.
18, 3658 (1990),
Abstract;
Molecular biology and biochemistry of the endothelins: M. Yanagisawa & T. Masaki; TIPS
10, 374 (1989),
Abstract;
The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes: A. Inoue, et al.; PNAS
86, 2863 (1989),
Abstract;
A novel potent vasoconstrictor peptide produced by vascular endothelial cells [see comments]: M. Yanagisawa, et al.; Nature
332, 411 (1988),
Abstract;
Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin: Y. Itoh, et al.; FEBS Lett.
231, 440 (1988),
Abstract;
Synthesis and disulfide structure determination of porcine endothelin: an endothelium-derived vasoconstricting peptide: S. Kumagaye, et al.; Int. J. Pept. Prot. Res.
32, 519 (1988),
Abstract;